Tarsus ex-officer plans $5.7M share sale
Tarsus Pharmaceuticals, Inc. (TARS) is the issuer for a Form 144 filed for the account of former officer Aziz A. Mottiwala.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Tarsus Pharmaceuticals, Inc. (TARS) is the issuer for a Form 144 filed for the account of former officer Aziz A. Mottiwala. The notice covers a proposed sale of up to 77,698 shares of common stock, planned in connection with a stock option exercise dated September 1, 2026. The securities are to be sold through Fidelity Brokerage Services LLC, with trading on NASDAQ. The filing also lists prior sales of common stock by Aziz A. Mottiwala during the past three months.
Key Figures
Key Terms
Form 144 regulatory
Rule 144 regulatory
stock option exercise financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing for TARS disclose about Aziz A. Mottiwala?
What prior sales of TARS stock by Aziz A. Mottiwala are reported?
AI-generated analysis. How Rhea-AI works. Not financial advice.